#oncogenomics

Spread the word! Personalized cancer medicine is the natural next step in the evolution of cancer treatment – and it's happening now! It won't be long before the traditional one-size-fits all approach to diagnosing and treating cancer is purely in our collective rear view mirror.

https://www.thestar.com/life/2017/11/06/personalized-cancer-plans-the-future-of-fighting-disease.html

Call CTOAM today to learn how precision oncology can benefit your own cancer treatment, diagnosis, and prevention.

Congratulations to PhD candidate, Caitlin Miron, who recently discovered a new DNA binder that can not only ‘switch off’ cancer cells but prevent them from spreading.

Miron says, “we are seeing therapeutic benefits in that cancer growth is reduced in some of the cell lines. The next step is to determine the best way to adapt this compound for use in humans.”

https://globalnews.ca/news/3874569/canadian-student-cancer-discovery/

New research in precision medicine is bringing cancer patients hope each day. If you want to learn how precision oncology can help you with your cancer treatment, prevention, or diagnosis, contact us anytime.

Get a FREE consultation, today!

Email: [email protected] Phone: +1 (778) 999-5463 Website: www.ctoam.com

Ever wonder what actually causes cancer? This is something everyone should be aware of, in order to both understand preventative measures and choose the best treatment approach.

Oncogenomics expert Alex Rolland explains the mechanisms behind cancer in this handy article:

https://www.ctoam.com/precision-oncology/education/explore-resources/educational-articles/what-causes-cancer/

If you have any questions about this, please email us today!

When it comes to cancer, there's no doubt that knowledge IS power. Understanding the disease will only help you to better exercise your rights as a patient (or as a supportive family member / friend), and make the best choices for you.

CTOAM: Changing the face of cancer care, one person at a time.

Phone: +1 (778) 999-5463

When facing a decision about cancer treatment, it’s so important to have an accurate understanding of the potential risks and outcomes of a given treatment.

However, as a recent study shows, oftentimes a cancer patient and their oncologist will have very different perceptions of what the patient's risk of death and chances of survival are.

Having a false understanding of the risks and survival likelihood associated with a treatment can harm the patient's ability to make a good treatment choice. It can also cause them unnecessary emotional stress and anxiety, as well as adversely affect recovery.

The study also points out that stress and anxiety tend to be highest with diseases that are known to be difficult to treat, such as Acute Myeloid Leukemia (AML). In fact, in many cases, patients do not understand the doctors terminology and how it applies to their circumstance. Read more on the study here: https://www.asco.org/about-asco/press-center/news-releases/people-leukemia-and-their-oncologists-have-vastly-different

Summarizing the main takeaway from the study results, Dr. El-Jawahri says:

“Clearly there are important communication gaps between oncologists and their patients. We need to find ways to help physicians do a better job of communicating with their patients, especially in diseases like AML where stress levels are remarkably high.”

One of the benefits of hiring a private company like CTOAM is that we act on your behalf as your professional advocate. Because we’re working for you directly – and NOT within the constraints of the medical system – you receive every piece of information regarding your disease, treatment options, risks, and recovery chances. We also make sure you understand all of your financial options (which can include getting full drug coverage through compassionate care) and update you on brand new treatment options as they emerge.

You can read about how our precision oncology specialists work with oncologists in the standard system to support them in helping you as much as possible.

Want to learn more or get a personalized consultation for your specific case, free of charge? Call +1 (778) 999-5463 or email us at [email protected].

The incidence of thyroid cancer has been steadily increasing over the last thirty years. Claiming more lives than all the other types of endocrine malignancies put together, thyroid cancer affects over 60,000 people each year in the US alone.

There are five main types of mutations that are known to be associated with thyroid cancer: BRAF, HRAS, KRAS, NRAS, and RET.

BRAF, one of the more common mutations, has two subtypes: AKAP-BRAF and BRAF V600E. Of these, BRAF V600E is the more prevalent.

Historically, BRAF V600E–mutated anaplastic thyroid cancer has been very difficult to treat.

Happily, there’s a new combination therapy that has been demonstrated to be quite promising for this type of cancer. In a recent study, 69% of patients with BRAF V600E–mutant anaplastic thyroid cancer in the study responded to a combination of the BRAF inhibitor Dabrafenib and the MEK inhibitor Trametinib.

Amazingly, the median durations of progression-free survival (PFS), and overall survival (OS) were not reached during the first 2.5 years of the study. 

Furthermore, the estimated progression-free survival (PFS) at 12 months was  79% and the overall survival (OS) was 80%.

This is an extremely significant discovery because it’s first time that a therapy has been shown to have robust clinical activity in BRAF V600E–mutant anaplastic thyroid cancer. Read more about the study here: http://www.ascopost.com/News/58232

For patients with BRAF V600E–mutant anaplastic thyroid cancer, this finding can mean the difference between life and death. If you’d like to know whether this combination therapy is likely to be effective for your unique form of thyroid cancer, contact our precision oncology specialists today! We’ll discuss your case in detail and explain the next steps in identifying the most effective treatment for your unique form of cancer.

Feel free to download our brochures to learn more: https://www.ctoam.com/about/brochures/

Phone: +1 (778) 999-5463

Email: [email protected]

 CTOAM: Changing the face of cancer care, one patient at a time.

New study shows that Proton Pump Inhibitors (PPIs) – drugs commonly used to treat acid reflux – may double the risk of stomach cancer when used long term.

Interestingly enough, using an H2 blocker did not increase the risk of stomach cancer at all.

Advancements in DNA sequencing continue to bring hope to patients with rare forms of cancer. The European Society for Medical Oncology (ESMO) explains how tumour sequencing allows specialists to determine which existing targeted therapies might work for rare cancers:

http://www.esmo.org/Press-Office/Press-Releases/DNA-Sequencing-Could-Open-Up-New-Drug-Indications-Patients-With-Rare-Cancers

 And you don’t need to live in Europe to benefit from these leading edge genetic tests! CTOAM offers access to the most comprehensive genetic panels available – for a fraction of what it costs in the United States and overseas in EU.

Learn more about DNA tumour sequencing here:

https://www.ctoam.com/services/testing/genetic-testing/how-it-works/genetic-panels/

And other types of advanced diagnostics and genetic testing:

https://www.ctoam.com/services/testing/

Contact us to discover how you can access these life-saving tests that will identify the specific genetic mutations driving your unique form of cancer.

Get your FREE consultation today!

Phone: +1 (778) 999-5463

Email: [email protected]

Here’s further evidence demonstrating the benefits of genetic testing and immunotherapy for cancer treatment: www.directorsblog.nih.gov/…/precision-oncology-gene-changes…

CTOAM has been using immunotherapy to help cancer patients for about five years now. Take a look at these patient success stories to see how genetic testing and immunotherapy work in practice:

https://www.ctoam.com/success-stories/patient-success-stories/julio/

https://www.ctoam.com/success-stories/patient-success-stories/lisa/

https://www.ctoam.com/success-stories/patient-success-stories/damian/

Learn more about genetic testing here: https://www.ctoam.com/services/testing/genetic-testing/

Contact CTOAM to learn how you can get the most medically advanced tests and treatments – for as close to free, and as close to home, as possible.

Get your FREE consultation, today!

[email protected]

+1 (778) 999-5463